share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M

SEC announcement ·  Jun 15 04:29
Summary by Futu AI
David M. Mott, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock on June 12, 2024. The shares were acquired at a price of $0.00, indicating the transaction was likely an exercise or conversion of derivative securities. Following this transaction, Mott's direct holdings in Novavax increased to a total of 50,470 shares. The nature of the transaction suggests an investment in the company's growth and potential, as Mott increases his stake in the pharmaceutical firm.
David M. Mott, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock on June 12, 2024. The shares were acquired at a price of $0.00, indicating the transaction was likely an exercise or conversion of derivative securities. Following this transaction, Mott's direct holdings in Novavax increased to a total of 50,470 shares. The nature of the transaction suggests an investment in the company's growth and potential, as Mott increases his stake in the pharmaceutical firm.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.